drugset / Trial / NCT07226817
A Study to Assess the Relative Bioavailability of BMS-986435 and Food Effect on the BMS-986435 in Healthy Adult Participants
Non-randomizedParallel-groupOpen-labelTreatment
Summary
This study is designed to evaluate the relative bioavailability (rBA) of multiple test tablet formulations of BMS-986435 compared to an equal dose of the BMS-986435 reference tablet formulation. The effect of food on the selected BMS-986435 tablet formulation will also be evaluated.
Timeline
- Start
- 2025-11-12
- Primary completion
- 2026-12-17
- Completion
- 2026-12-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | DELOCAMTEN | Small molecule | — | — |
Indications
No indication recorded.